Genetic variants of the tumour necrosis factor-alpha promoter gene do not influence the development of necrotizing enterocolitis

Acta Paediatrica, International Journal of Paediatrics

Volumn 90, Issue 10, 2001, Pages 1182-1185

  Treszl, A ^a   Kocsis, I ^a   Szathmari M ^a   Tulassay, T ^a   Vasarhelyi B ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Genetic polymorphism; Necrotizing enterocolitis; Tumour necrosis factor alpha; Very low birthweight infants

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE COURSE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; NECROTIZING ENTEROCOLITIS; NEWBORN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; VERY LOW BIRTH WEIGHT;

ADENINE; ALLELES; ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034788298     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/080352501317061611     Document Type: Article

References (21)

1. Epidemiology of necrotizing enterocolitis
2. Platelet-activating factor, tumor necrosis factor, hypoxia and necrotizing enterocolitis
3. The central role of PAF in necrotizing enterocolitis development
4. Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor
5. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis
6. Inflammatory cytokine mRNAs in surgical specimens of necrotizing enterocolitis and normal newborn intestine
7. Elevations of interleukin-6 in neonatal sepsis and necrotizing enterocolitis (NEC)
8. Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis
9. Identity of turnout necrosis factor and the macrophage-secreted factor cachectin
10. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation
11. Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying TNF-alpha 238A promoter polymorphism
12. Neonatal necrotizing enterocolitis: Therapeutic decisions based upon clinical staging
13. The frequency of medium chain acyl CoA dehydrogenase G985 mutation in Hungary
14. Polymorphism of TNF-alpha, LT-alpha, the IL-6 promoter and the IL-1 receptor antagonist at the DNA level in a Hungarian population and the relation to infectious, autoimmune and malignant diseases
15. Turnout necrosis factor haplotypes and asthma
16. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease
17. Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid
18. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria
19. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: A multicenter study
20. Pilot study assessing TNF gene polymorphism as a prognostic marker for disease progression in neonates with sepsis
21. Tumor necrosis factor/cachectin and interleukin secretion by cord blood monocytes from premature and term neonates